Left ventricular remodelling in post-myocardial infarction patients with left ventricular ejection fraction 40-50% vs 25-39%. Influence of nisoldipine treatment?

Scandinavian Cardiovascular Journal

Volumn 33, Issue 4, 1999, Pages 234-241

  Otterstad, Jan Erik ^a   Lubsen, Koos ^b   Parker, Andrea ^b   Kirwan, Bridget ^b   Plappert, Ted ^c   St John Sutton, Martin G ^c  

^a Vestfold Central Hospital   (Norway)

^b SOCAR RESEARCH SA   (Switzerland)

^c HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Left ventricular remodelling; Post myocardial infarction ejection fraction 40

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; NISOLDIPINE;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; FOLLOW UP; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TIME; TREATMENT OUTCOME; TWO DIMENSIONAL ECHOCARDIOGRAPHY;

ADULT; AGED; CALCIUM CHANNEL BLOCKERS; DOUBLE-BLIND METHOD; ECHOCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; NISOLDIPINE; STROKE VOLUME; ULTRASONOGRAPHY, DOPPLER; VENTRICULAR REMODELING;

EID: 0032832582     PISSN: 14017431     EISSN: None     Source Type: Journal    
DOI: 10.1080/14017439950141678     Document Type: Article

References (15)

1. Erlebacher JA, Weiss JL, Kallman C, Weisfeldt ML, Bulkley BH. Late effects of acute infarct dilatation on heart size: a two-dimensional echocardiographic study. Am J Cardiol 1982; 49: 1120-1126.
2. Sharpe N, Smith H, Murphy J, Freaves S, Hart H, Gamble G. Early prevention of left ventricular dysfunction after myocardial infarction with angiotensin-converting-enzyme inhibition. Lancet 1991; 337: 872-876.
3. Søgaard P, Gøtsche CO, Ravkilde J, Thygesen K. Effects of captopril on ischemia and dysfunction of the left ventricle after myocardial infarction. Circulation 1993; 87: 1093-1009.
4. St. John Sutton MG, Pfeffer MA, Plappert T, et al. Quantitative two-dimensional echocardiographic measurements are major predictors of adverse cardiovascular events after acute myocardial infarction. The protective effects of captopril. Circulation 1994; 89: 68-75.
5. GISSI-3: Effects of lisinopril and transdermal glyceryl trinitrate singly and together on 6-week mortality and ventricular function after myocardial infarction. Gruppo Italiano per'lo Studio delta Sopravivenza nellinfarto Miocardico. Lancet 1994; 343: 1115-1122.
6. Pfeffer MA, St. John Sutton MG. Left ventricular remodelling after myocardial infarction. In: St. John Sutton MG. Left ventricular remodelling after myocardial infarction. London: Science Press, 1996: 1-10.
7. White HD, Norris RM, Brown MA, et al. Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction. Circulation 1987; 76: 44-51.
8. Hall A, Cleland JGF, Erhardt L, Murray GD, Ball SG. Effect of ramipril on the mortality of patients after myocardial infarction with clinical evidence of heart failure and a systolic ejection fraction < 40%: an AIRE substudy. Eur Heart J 1996; 17: Abstr. Suppl: 408.
9. Doppler flow and echocardiography in functional cardiac insufficiency: assessment of nisoldipine therapy. Results of the DEFIANT-II study. The DEFIANT-II Research Group. Eur Heart J 1997; 18: 31-40.
10. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-dimensional Echocardiograms. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. Am Soc Echocardiogr 1989; 2: 358-367.
11. Otterstad JE, Froeland G, St. John Sutton MG, Holme I. Accuracy and reproducibility of biplane two-dimensional echocardiographic measurements of left ventricular dimensions and function. Eur Heart J 1997; 18: 507-513.
12. Packer M, Bristow MR, Cihn JN, et al. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. N Engl J Med 1996; 334: 1349-1355.
13. Doughty RN, Whalley GA, Gamble G, MacMahon S, Sharpe N. Left ventricular remodeling with carvedilol in patients with congestive heart failure due to ischemic heart disease. J AM Coll Cardicl 1997; 29: 1061-1066.
14. Australia/New Zealand Heart Failure Research Collaborative Group. Randomised, placebo-controlled trial of carvedilol in patients with congestive heart failure due to ischaemic heart disease. Lancet 1997; 359: 375-380.
15. Beltrami CA, Finato N, Rocco M, et al. Structural basis of end-stage failure in ischemic cardiomyopathy in humans. Circulation 1994; 89: 151-163.